Erythrocyte Disorders in Infancy

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 1180-1214

  Mentzer, William C ^a,b,c   Glader, Bertil E ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Washington University   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882559876     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50079-2     Document Type: Chapter

References (217)

1. Allen DW, Wyman J, Smith GA The oxygen equilibrium of fetal and adult hemoglobin. J Biol Chem 1953, 203:81.
2. Bauer C, Ludwig I, Ludwig M Different effects of 2,3-diphosphoglycerate and adenosine triphosphate on oxygen affinity of adult and fetal hemoglobin. Life Sci 1968, 7:1339.
3. Delivoria-Papadopoulos M, Roncevic NP, Oski FA Postnatal changes in oxygen transport of term, premature, and sick infants: The role of red cell 2,3-diphosphoglycerate and adult hemoglobin. Pediatr Res 1971, 5:235.
4. Finne PH Erythropoietin levels in cord blood as an indicator of intrauterine hypoxia. Acta Paediatr Scand 1966, 55:478.
5. Finne PH, Halvorsen S Regulation of erythropoiesis in the fetus and newborn. Arch Dis Child 1972, 47:683.
6. Gairdner D, Marks J, Roscoe JD, et al. The fluid shift from the vascular compartment immediately after birth. Arch Dis Child 1958, 33:489.
7. Jacobson LO, Marks EK, Gaston EO Studies on erythropoiesis. XII. The effect of transfusion-induced polycythemia in the mother on the fetus. Blood 1959, 14:644.
8. Lanzkowsky P The influence of maternal iron deficiency on the haemoglobin of the infant. Arch Dis Child 1961, 36:205.
9. Oski FA, Delivoria-Papadopoulos M The red cell, 2,3-diphosphoglycerate, and tissue oxygen release. J Pediatr 1970, 77:941.
10. Usher R, Lind J Blood volume of the newborn premature infant. Acta Paediatr Scand 1965, 54:419.
11. Usher R, Shepard M, Lind J The blood volume of the newborn infant and placental transfusion. Acta Paediatr Scand 1963, 52:497.
12. Zon LI Developmental biology of hematopoiesis. Blood 1995, 86:2876.
13. Alter BE Methods in Haematology, vol 21: Perinatal Haematology 1989, Churchill Livingstone, Edinburgh.
14. Brady MT, Milam JD, Anderson DC, et al. Use of deglycerolized red blood cells to prevent posttransfusion infection with cytomegalovirus in neonates. J Infect Dis 1984, 150:334.
15. Demmler GJ, Brady MT, Bijou H, et al. Posttransfusion cytomegalovirus infection in neonates: Role of saline-washed red blood cells. J Pediatr 1986, 108:762.
16. Engelfriet CP, Reesink HW Red cell transfusions in neonatal care. Vox Sang 2001, 80:122.
17. Enoki M, Goto R, Goto A, et al. Graft-versus-host reaction in an extremely premature infant after repeated blood transfusions. Acta Neonatol Jpn 1985, 21:696.
18. Gilbert GL, Hayes K, Hudson IL, et al. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Lancet 1989, 1:1228.
19. Goldman MJ, Garcia C, Spurll G Reduction of donor exposures in premature infants by the use of designated adenine-saline preserved split red blood cell packs. J Perinatol 2001, 21:363.
20. Naiman JL, Punnett HH, Lischner HW, et al. Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis. N Engl J Med 1969, 281:697.
21. Oh W, Lind J Venous and capillary hematocrit in newborn infants and placental transfusion. Acta Paediatr Scand 1966, 55:38.
22. Parkman R, Mosier D, Umansky I, et al. Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. N Engl J Med 1974, 209:359.
23. Sanders MR, Graeber JE, Vogelsang G, et al. Posttransfusion graft versus host disease in a premature infant without known risk factors. Pediatr Res 1989, 25:272A.
24. Strauss RG, Burmeister LF, Johnson K, et al. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 2000, 136:215.
25. Yeager AS, Grumet FC, Hafleigh EB, et al. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981, 98:281.
26. Chapman JF, Bain BJ, Bates SC, et al. The estimation of fetomaternal haemorrhage. Transfusion Medicine 1999, 9:87.
27. Cohen F, Zuelzer WW, Gustafson DC, Evans MM Mechanisms of isoimmunization. I. The transplacental passage of fetal erythrocytes in homo-specific pregnancies. Blood 1964, 23:621.
28. Danskin FH, Neilson JP Twin-to-twin transfusion syndrome: What are appropriate diagnostic criteria?. Am J Obstet Gynecol 1989, 161:365.
29. Fong EA, Davies JI, Grey DE, et al. Detection of massive transplacental haemorrhage by flow cytometry. Clin Lab Haem 2000, 22:325.
30. Leonard S, Anthony B Giant cephalohematoma of newborn. Am J Dis Child 1961, 101:170.
31. Montague ACW, Krevans JR Transplacental hemorrhage in cesarean section. Am J Obstet Gynecol 1966, 95:1115.
32. Nieburg PI, Stockman JA Rapid correction of anemia with partial exchange transfusion. Am J Dis Child 1977, 131:60.
33. Oski FA, Naiman JL Hematologic Problems in the Newborn 1982, WB Saunders, Philadelphia. 3rd ed.
34. Pearson HA, Diamond LK Fetomaternal transfusion. Am J Dis Child 1959, 97:267.
35. Rausen AR, Seki M, Strauss L Twin transfusion syndrome. A review of 19 cases studied at one institution. J Pediatr 1965, 66:613.
36. Raye JR, Gutberlet RL, Stahlman M Symptomatic posthemorrhagic anemia in the newborn. Pediatr Clin North Am 1970, 17:401.
37. Seng YC, Rajadurai VS Twin-twin transfusion syndrome: A five year review. Arch Dis Child Fetal Neonatal Ed 2000, 83:F168.
38. Shepherd AJ, Richard J, Brown JP Nuchal cord as a cause of neonatal anemia. Am J Dis Child 1985, 139:71.
39. Van Gemert MJC, Umur A, Tijssen JGP, Ross MG Twin-twin transfusion syndrome: Etiology, severity and rational management. Curr Opin Obstet Gynecol 2001, 13:193.
40. Woo Wang MYF, McCutcheon E, Desforges JF Fetomaternal hemorrhage from diagnostic transabdominal amniocentesis. Am J Obstet Gynecol 1967, 97:1123.
41. Zipursky A, Pollock J, Chown B, Israels LG Transplacental fetal maternal hemorrhage after placental injury during delivery or amniocentesis. Lancet 1963, 2:493.
42. a, anti-S, and anti-Good. Transfusion 1961, 1:116.
43. Austin RF, Desforges JF Hereditary elliptocytosis: An unusual presentation of hemolysis in the newborn associated with transient morphologic abnormalities. Pediatrics 1969, 44:196.
44. Bader-Meunier B, Gauthier F, Archambaud F, et al. Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood 2001, 97:399.
45. Bard H The postnatal decline of hemoglobin F synthesis in normal full-term infants. J Clin Invest 1975, 55:395.
46. Batton DG, Amanullah A, Comstock C Fetal schistocytic hemolytic anemia and umbilical vein varix. J Pediatr Hematol Oncol 2000, 22:259.
47. Beaudry MA, Ferguson DJ, Pearse K, et al. Survival of a hydropic infant with homozygous alpha-thalassemia-1. J Pediatr 1986, 108:713.
48. Bennett PR, Le Van Kim C, Colin Y, et al. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993, 329:607.
49. Beutler E, Vulliamy T, Luzzatto L Hematologically important mutations: Glucose-6-phosphate dehydrogenase. Blood Cells, Mol Dis 1996, 22:49.
50. Bianchi DW, Beyer EC, Stark AR, et al. Normal long-term survival with alpha-thalassemia. J Pediatr 1986, 108:716.
51. Technical Manual 2002, American Association of Blood Banks, Bethesda, Md. 14th ed. M.E. Brecher (Ed.).
52. Brouwers HAA, Overbeeke MAM, van Ertbrugeen I, et al. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?. Lancet 1988, 2:641.
53. Brown AK Hyperbilirubinemia in black infants: Role of glucosephosphate dehydrogenase deficiency. Clin Pediatr 1992, 31:712.
54. Cao A, Galanello R, Rosatelli MC, et al. Clinical experience of management of thalassemia: The Sardinian experience. Semin Hematol 1996, 33:66.
55. Chen FE, Ool C, Yin S, et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 2000, 343:544.
56. Chik KW, Shing MM, Leung TF, et al. Treatment of hemoglobin Bart's hydrops with bone marrow transplantation. J Pediatr 1998, 132:1039.
57. Chui DHK, Waye JS Hydrops fetalis caused by α-thalassemia: An emerging health care problem. Blood 1998, 91:2213.
58. Delhommeau F, Cynober T, Schischmanoff PO, et al. Natural history of hereditary spherocytosis during the first year of life. Blood 2000, 95:393.
59. Diamond LK Splenectomy in childhood and the hazard of overwhelming infection. Pediatrics 1969, 43:886.
60. Diaz-Barrios V New York's experience. Pediatrics (Suppl) 1989, 83:2.
61. Doxiadis SA, Valaes T The clinical picture of glucose-6-phosphate dehydrogenase deficiency in early infancy. Arch Dis Child 1964, 39:545.
62. Embury SH, Kropp GL, Stanton TS Detection of the hemoglobin E mutation using the color complementation assay: Application to complex genotyping. Blood 1990, 78:619.
63. Eshaghpour E, Oski FA, Williams M The relationship of erythrocyte glucose-6-phosphate dehydrogenase deficiency to hyperbilirubinemia in Negro premature infants. J Pediatr 1967, 70:595.
64. Fisk NM, Bennett P, Warwick RM, et al. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi. Am J Obstet Gynecol 1994, 171:50.
65. Freda VJ, Gorman JG, Pollack W, Bowe E Prevention of Rh hemolytic disease: 10 years' clinical experience with Rh immune globulin. N Engl J Med 1975, 292:1014.
66. Fucharoen S, Ketvichit P, Pootrakul P, et al. Clinical manifestation of beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol 2000, 22:552.
67. Galanello R Molecular basis of thalassemia major. Int J Pediatr Hematol Oncol 1995, 2:383.
68. Gallagher PG, Petruzzi MJ, Weed SA, et al. Mutation of a highly conserved residue of β1 spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest 1997, 99:267.
69. Gaston MH, Vertier JI, Wood G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med 1986, 314:1593.
70. Glader BE, Look K Hematologic disorders in children in Southeast Asia. Pediatr Clin North Am 1996, 43:665.
71. Grannum PA, Copel JA, Moya FR, et al. The reversal of hydrops fetalis by intravascular transfusion in severe isoimmune fetal anemia. Am J Obstet Gynecol 1988, 158:914.
72. Grannum PA, Copel JA, Plaxe SC, et al. In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis. N Engl J Med 1986, 314:1431.
73. Huang CS, Hung KL, Huang MJ, et al. Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. Am J Hematol 1996, 51:19.
74. Judd WJ Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001, 41:1445-1452.
75. Kan YW, Forget BG, Nathan DG Gamma-beta thalassemia: A cause of hemolytic disease of the newborn. N Engl J Med 1972, 286:129.
76. Kaplan M, Algur N, Hammerman C Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatr 2001, 108:956.
77. Kaplan M, Beutler E, Vreman HJ, et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. Pediatr 1999, 104:68.
78. Kaplan M, Hammerman C, Beutler E Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome. Eur J Pediatr 2001, 160:195.
79. Kaplan M, Hammerman C, Feldman R, et al. Predischarge bilirubin screening in glocose-6-phosphate dehydrogenase-deficient neonates. Pediatr 2000, 105:533.
80. Kaplan E, Herz F, Scheye E ABO hemolytic disease of the newborn, without hyperbilirubinemia. Am J Hematol 1976, 1:279.
81. Kaplan M, Vreman HJ, Hamerman C, et al. Favism by proxy in nursing glucose-6-phosphate dehydrogenase-deficient neonates. J Perinatol 1998, 18:477.
82. Kappas A, Drummond GS, Manola T, et al. Sn-protoporphyrin use in the management of hyperbilirubinemia in term infants with direct Coombs-positive ABO incompatibility. Pediatrics 1988, 81:485.
83. Kappas A, Drummond GS, Valaes T A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001, 108:25.
84. Kazazian HH, Boehm CD Molecular basis and prenatal diagnosis of β-thalassemia. Blood 1988, 72:1107.
85. 241(C7) Phe6Ser in a newborn with cyanosis. Am J Hematol 1995, 49:43.
86. Koshy M, Burd L Obstetric and gynecologic issues. Sickle Cell Disease: Basic Principles and Clinical Practice 1995, 689. Raven Press, New York. S.H. Embury, R.P. Hebbel, N. Mohandas, M.H. Steinberg (Eds.).
87. LaCelle PL Alteration of membrane deformability in hemolytic anemias. Semin Hematol 1970, 7:355.
88. Lenfant C The Management of Sickle Cell Disease. National Institutes of Health Publication No 02-2117 2002, National Heart, Lung, and Blood Institute, Bethesda, MD, Also available on line: http://www.nhlbi.nih.gov. 4th ed.
89. Levine P, Burnham L, Katzen EM, Vogel P The role of isoimmunization and the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol 1941, 42:925.
90. Liley AW Liquor amnii analysis in the management of pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol 1961, 82:1359.
91. Liley AW Intrauterine transfusion of fetus in hemolytic disease. BMJ 1963, 2:1107.
92. Lorey F, Arnopp J, Cunningham GC Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol 1996, 13:501.
93. Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Testing 2000, 5:93.
94. Luzzatto L Glucose-6-phosphate dehydrogenase deficiency and hemolytic anemia. Nathan and Oski's Hematology of Infancy and Childhood 1998, WB Saunders, Philadelphia. 5th ed. D.G. Nathan, S.H. Orkin (Eds.).
95. Lyon MF Gene action in the X-chromosome of the mouse. Nature 1961, 190:372.
96. Matthay KK, Mentzer WC Erythrocyte enzymopathies in the newborn. Clin Haematol 1981, 10:31.
97. McDonagh KT, Nienhuis AW The thalassemias. Hematology of Infancy and Childhood 1993, 783. WB Saunders, Philadelphia. 4th ed. D.G. Nathan, F.A. Oski (Eds.).
98. Meloni T, Forteleoni G, Meloni GF Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: The northern Sardinian experience. Acta Haematol 1992, 87:29.
99. Mentzer WC Pyruvate kinase deficiency and disorders of glycolysis. Hematology of Infancy and Childhood 2003, 685. WB Saunders, Philadelphia. 6th ed. D.G. Nathan, S.H. Orkin, A.T. Look, D. Ginsburg (Eds.).
100. Mentzer WC, Collier E Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid. J Pediatr 1975, 86:565.
101. Mentzer WC, Glader BE Hereditary spherocytosis and other anemias due to abnormalities of the red cell membrane. Wintrobe's Clinical Hematology 2004, 1089. Lippincott Williams & Wilkins, Philadelphia. 11th ed. J.P. Greer, J. Foerster, J.N. Lukens (Eds.).
102. Mentzer WC, Iarocci TA, Mohandas N, et al. Modulation of erythrocyte membrane mechanical stability by 2,3-diphosphoglycerate in the neonatal poikilocytosis/elliptocytosis syndrome. J Clin Invest 1987, 79:943.
103. Miwa S, Fujii H Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: Tabulation of mutant enzymes. Am J Hematol 1996, 51:122.
104. Mouro I, Colin Y, Cherif-Zahar B, et al. Molecular genetic basis of the human rhesus blood group system. Nature Genet 1993, 5:62.
105. Nicolaides JH, Soothill PW, Clewell WH, et al. Fetal hemoglobin measurement in the assessment of red cell isoimmunization. Lancet 1988, 1:1073.
106. O'Flynn MED, Hsia DY Serum bilirubin levels and glucose-6-phosphate dehydrogenase deficiency in newborn American Negroes. J Pediatr 1963, 63:160.
107. Olivieri NF The β-thalassemias. N Engl J Med 1999, 341:99.
108. Osborn LM, Lenarsky C, Oakes RC, et al. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics 1984, 74:371.
109. Ovali F, Samanci N, Dagoglu T, et al. Management of late anemia in rhesus hemolytic disease: Use of recombinant human erythropoietin (a pilot study). Pediatr Res 1996, 39:831.
110. Palek J, Jarolim P Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol 1993, 30:249.
111. Parer JT Severe Rh isoimmunization: Current methods of in utero diagnosis and treatment. Obstet Gynecol 1988, 158:1323.
112. Pearson HA Life-span of the fetal red blood cell. J Pediatr 1967, 70:166.
113. Reed W, Lane PA, Lorey F, et al. Sickle-cell disease not identified by newborn screening because of prior transfusion. J Pediatr 2000, 136:248.
114. Rodeck CH, Nicolaides KH, Warsof SL, et al. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol 1984, 150:769.
115. Scaradavou A, Inglis S, Peterson P, et al. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: Use of erythropoietin to treat the late anemia. J Pediatr 1993, 123:279.
116. Schröter W, Kahsnitz E Diagnosis of hereditary spherocytosis in newborn infants. J Pediatr 1983, 103:460.
117. Singer ST, Styles L, Bojanowski J, et al. Changing outcome of homozygous α-thalassemia: Cautious optimism. J Pediatr Hematol Oncol 2000, 22:539.
118. Spinnato JA Hemolytic disease of the fetus: A plea for restraint. Obstet Gynecol 1992, 80:873.
119. Stamatoyannopoulos G Gamma-thalassemia. Lancet 1971, 2:192.
120. Stamey CC, Diamond LK Congenital hemolytic anemia in the newborn. Am J Dis Child 1957, 94:616.
121. Tchernia G, Gauthier F, Mielot F, et al. Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis. Blood 1993, 81:2014.
122. Valaes T Severe neonatal jaundice associated with glucosephosphate dehydrogenase deficiency: Pathogenesis and global epidemiology. Acta Paediatr Suppl 1994, 394:58.
123. Valaes T, Petmezaki S, Henschke C, et al. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: Studies with tin-mesoporphyrin. Pediatrics 1994, 93:1.
124. Veiga S, Vaithianathan T Massive intravascular sickling after exchange transfusion with sickle cell trait blood. Transfusion 1963, 3:387.
125. Voak D, Williams MA An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO hemolytic disease of the newborn and observations on pinocytosis of IgG anti-A antibodies by infant (cord) red cells. Br J Haematol 1971, 20:9.
126. Weiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. Am J Obstet Gynecol 1991, 165:1302.
127. Wethers D, Pearson H, Gaston M Newborn screening for sickle cell disease and other hemoglobinopathies. Pediatrics (Suppl) 1989, 83:813.
128. Zanella A, Bianchi P Red cell pyruvate kinase deficiency: From genetics to clinical manifestations. Baillieres Clin Haematol 2000, 13:57.
129. Zipursky A, Pollock J, Chown B, et al. Transplacental fetal hemorrhage after placental injury during delivery or amniocentesis. Lancet 1963, 2:493.
130. Alter BP The inherited bone marrow failure syndromes. Nathan and Oski's Hematology of Infancy and Childhood 2003, 280. WB Saunders, Philadelphia. 6th ed. D.G. Nathan, S.H. Orkin (Eds.).
131. Diamond LK, Blackfan KD Hypoplastic anemia. Am J Dis Child 1938, 56:464.
132. Gazda H, Lipton JM, Willig TN, et al. Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non 8p disease. Blood 2000, 97:2145.
133. Glader BE Diagnosis and management of red cell aplasia in children. Hematol Oncol Clin North Am 1987, 1:431.
134. Gustavsson P, Willig TN, van Haeringen A, et al. Diamond-Blackfan anaemia: Genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb. Nat Genet 1997, 16:368.
135. Lipton JM, Federman N, Khabbaze Y, et al. Osteogenic sarcoma associated with Diamond-Blackfan anemia: A report from the Diamond Blackfan Anemia Registry. J Pediatr Hematol Oncol 2001, 23:377.
136. Miller R, Berman B Transient erythroblastopenia of childhood in infants <6 months of age. Am J Pediatr Hematol Oncol 1994, 16:246.
137. Rogers ZR, Bergstrom SK, Amylon MD, et al. Reduced neutrophil counts in children with transient erythroblastopenia of childhood. J Pediatr 1989, 15:746.
138. Vlachos A, Federman N, Reyes-Haley C, et al. Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: A report from the Diamond Blackfan Anemia Registry. Bone Marrow Transplant 2001, 27:381.
139. Wranne L Transient erythroblastopenia in infancy and childhood. Scand J Haematol 1970, 7:76.
140. Ware RE, Kinney TR Transient erythroblastopenia in the first year of life. Am J Hematol 1991, 37:156.
141. Alagappan A, Shattuck KE, Malloy MH Impact of transfusion guidelines on neonatal transfusions. J Perinatology 1998, 18:92.
142. Batton DG, Goodrow D, Walker RH Reducing neonatal transfusions. J Perinatol 1992, 12:152.
143. Bifano EM, Smith F, Borer J Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia. J Pediatr 1992, 120:292.
144. Blank JP, Sheagren TG, Vajara J, et al. The role of RBC transfusion in the premature infant. Am J Dis Child 1984, 138:831.
145. Brown MS, Berman ER, Luckey D Prediction of the need for transfusion during anemia of prematurity. J Pediatr 1990, 116:773.
146. Christensen RD, Liechty KW, Koenig JM, et al. Administration of erythropoietin to newborn rats results in diminished neutrophil production. Blood 1991, 78:1241.
147. Cook S, Gunter J, Wissel M Effective use of a strategy using assigned red cell units to limit donor exposure for neonatal patients. Transfusion 1993, 33:379.
148. Dallman PR Anemia of prematurity: The prospects for avoiding blood transfusions with recombinant erythropoietin. Adv Pediatr 1993, 40:385.
149. Davis P, Herbert M, Davies DP, et al. Erythropoietin for anaemia in a preterm Jehovah's Witness baby. Early Hum Dev 1991, 1:279.
150. Emmerson AJB, Coles HJ, Stern CMM, et al. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993, 63:291.
151. Engelfriet CP, Reesink HW, Strauss RG, et al. Red cell transfusions in neonatal care. Vox Sang 2001, 80:122.
152. Frey B, Losa M The value of capillary whole blood lactate for blood transfusion requirements in anaemia of prematurity. Intensive Care Med 2001, 27:222.
153. Gallagher PG, Ehrenkranz RA Erythropoietin therapy for anemia of prematurity. Clin Perinatol 1993, 20:169.
154. Goldman MJ, Garcia C, Spurll G Reduction of donor exposures in premature infants by the use of designated adenine-saline preserved split red blood cell packs. J Perinatol 2001, 21:363.
155. Graeber JE, Williams ML, Oski FA The use of intramuscular vitamin E in the premature infant. J Pediatr 1977, 90:282.
156. Heese H De V, Smith S, Watermeyer S, et al. Prevention of iron deficiency in preterm neonates during infancy. S Afr Med J 1990, 77:339.
157. Izraeli S, Ben-Sira L, Harell D, et al. Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of prematurity. J Pediatr 1993, 122:629.
158. Joshi A, Gerhardt T, Schandloff P, et al. Blood transfusion effect on the respiratory pattern of premature infants. Pediatrics 1987, 80:79.
159. Keyes WG, Donohue PK, Spivak JL, et al. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs and erythropoietin level. Pediatrics 1989, 84:412.
160. Lachance C, Chessex P, Fouron JC, et al. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. J Pediatr 1994, 125:278.
161. Liu EA, Mannino FL, Lane TA Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr 1994, 125:92.
162. Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994, 330:1173.
163. Mentzer WC, Shannon KM The use of recombinant human erythropoietin in preterm infants. Int J Pediatr Hematol Oncol 1995, 2:97.
164. Mestyan J, Fekete M, Bata G, et al. The basal metabolic rate of premature infants. Biol Neonatol 1964, 7:11.
165. Meyer MP, Meyer JH, Commerford A, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study. Pediatrics 1994, 93:918.
166. Nelle M, Höcker C, Zilow EP, et al. Effects of red cell transfusion on cardiac output and blood flow velocities in cerebral and gastrointestinal arteries in premature infants. Arch Dis Child 1994, 71:F45.
167. Oski FA, Barness LA Vitamin E deficiency: A previously unrecognized cause of hemolytic anemia in the premature infant. J Pediatr 1967, 70:211.
168. Oski FA, Naiman JL Hematologic Problems in the Newborn 1982, WB Saunders, Philadelphia. 3rd.
169. Ritchie JH, Fish MB, McMasters V, et al. Edema and hemolytic anemia in premature infants. N Engl J Med 1968, 279:1185.
170. Ross MP, Christensen RD, Rothstein G, et al. A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. J Perinatol 1989, 9:246.
171. Shannon KM Anemia of prematurity: Progress and prospects. Am J Pediatr Hematol Oncol 1990, 12:14.
172. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995, 95:1.
173. Shannon KM, Naylor GS, Torkildson JC, et al. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 1987, 317:728.
174. Shireman TI, Hilsenrath PE, Strauss RG, et al. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. Arch Pediatr Adolesc Med 1994, 148:582.
175. Stockman JA, Clark DA Weight gain: A response to transfusion in selected preterm infants. Am J Dis Child 1984, 138:828.
176. Stockman JA, Graeber JE, Clark DA, et al. Anemia of prematurity: Determinants of the erythropoietin response. J Pediatr 1984, 105:786.
177. Strauss RG Erythropoietin and neonatal anemia. N Engl J Med 1994, 330:1227.
178. Strauss RG Transfusion therapy in neonates. Am J Dis Child 1991, 145:904.
179. Strauss RG, Burmeister LF, Johnson K, et al. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 2000, 136:215.
180. Vamvakas EC, Strauss RG Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 2001, 41:406.
181. Wandstrat TL, Kaplan B Use of erythropoietin in premature neonates: Controversies and the future. Pediatrics 1995, 29:166.
182. Wardrop CA, Holland BM, Veale KE, et al. Nonphysiological anaemia of prematurity. Arch Dis Child. 1978, 53:855.
183. 12 to reduce the severity of the anemia of prematurity. Am J Clin Nutr 1994, 60:930.
184. Zipursky A, Brown EJ, Watts J, et al. Oral vitamin E supplementation for the prevention of anemia in premature infants: A controlled trial. Pediatrics 1987, 79:61.
185. Zipursky A Erythropoietin therapy for premature infants: Cost without benefit?. Pediatr Res 2000, 48:136.
186. Black VD, Rumack CM, Lubchenko LO, et al. Gastrointestinal injury in polychemic term infants. Pediatrics 1985, 76:225.
187. Carmi D, Wolach B, Dolfin T, et al. Polycythemia of the preterm and full-term newborn infant: Relationship between hematocrit and gestational age, total blood solutes, reticulocyte count, and blood pH. Biol Neonate 1992, 61:173.
188. Delaney-Black V, Camp BW, Lubchenko LO, et al. Neonatal hyperviscosity association with lower achievement and IQ scores at school age. Pediatrics 1989, 83:662.
189. Gatti RA, Muster AJ, Cole RB, et al. Neonatal polycythemia with transient cyanosis and cardiorespiratory abnormalities. J Pediatr 1966, 69:1063.
190. Hein HA, Lathrop SS Partial exchange transfusion in term, polycythemic neonates: Absence of association with severe gastrointestinal injury. Pediatrics 1987, 80:75.
191. Kerrigan JF, Aleck KA, Tarby TJ, et al. Fumaric aciduria: Clinical and imaging features. Ann Neurol 2000, 47:583.
192. Kurlat I, Sola A Neonatal polycythemia in appropriately grown infants of hypertensive mothers. Acta Paediatr 1992, 81:662.
193. Levy I, Pmerlob P, Ashkenazi S, et al. Neonatal polycythaemia: Effort of partial dilutional exchange transfusion with human albumin on whole blood viscosity. Eur J Pediatr 1990, 149:354.
194. Mentzer WC Polycythaemia and the hyperviscosity syndrome in newborn infants. Clin Haematol 1978, 7:63.
195. Norman M, Fagrell B, Herin P Effects of neonatal polycythemia and hemodilution on capillary perfusion. J Pediatr 1992, 121:103.
196. Norman M, Fagrell B, Herin P Skin microcirculation in neonatal polycythaemia and effects of haemodilution. Interaction between haematocrit, vasomotor activity and perfusion. Acta Paediatr 1993, 82:672.
197. Oh W, Omori K, Emmanouilides GC, Phelps DL Placenta to lamb fetus transfusion in utero during acute hypoxia. Am J Obstet Gynecol 1975, 122:316.
198. Oski FA, Naiman JL Hematologic Problems in the Newborn 1982, WB Saunders, Philadelphia. 3rd.
199. Ramamurthy RS, Berlanga M Postnatal alteration in hematocrit and viscosity in normal and polycythemic infants. J Pediatr 1987, 110:929.
200. Shohat M, Merlob P, Reisner SH Neonatal polycythemia: Early diagnosis and incidence relating to time of sampling. Pediatrics 1984, 73:7.
201. Villalta IA, Pramanik AK, Diaz-Blanco J, et al. Diagnostic errors in neonatal polycythemia based on method of hermatocrit determination. J Pediatr 1989, 115:460.
202. Bartos HR, Desforges JF Erythrocyte DPNH dependent diaphorase levels in infants. Pediatrics 1966, 37:991.
203. Climie CR, McLean S, Starmer GA, Thomas J Methaemoglobinaemia in mother and foetus following continuous epidermal analgesia with prilocaine. Br J Anaesthesiol 1967, 39:155.
204. Comly HR Cyanosis in infants caused by nitrates in well water. JAMA 1945, 129:112.
205. Couper R Methaemoglobinaemia secondary to topical lignocaine/prilocaine in a circumcised neonate. J Paediatr Child Health 2000, 36:406.
206. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998, 101:325.
207. Harley JD, Celermajer JM Neonatal methaemoglobinaemia and the "red-brown" screening test. Lancet 1970, 2:1223.
208. Hayashi A, Fujita T, Fujimura M, et al. A new abnormal fetal hemoglobin, Hb FM-Osaka. Hemoglobin 1980, 4:447.
209. Kay MA, O'Brien W, Kessler B, et al. Transient organic-aciduria and methemoglobinemia with acute gastroenteritis. Pediatrics 1990, 85:589.
210. Keating JP, Lell ME, Strauss AW, et al. Infantile methemoglobinemia caused by carrot juice. N Engl J Med 1973, 288:824.
211. Martin H, Huisman THJ Formation of ferrihaemoglobin of isolated human haemoglobin types by sodium nitrate. Nature 1963, 200:898.
212. Murray KF, Christie DL Dietary protein intolerance in infants with transient methemoglobinemia and diarrhea. J Pediatr 1993, 122:90.
213. Porat R, Gilbert S, Magilner D Methylene blue-induced phototoxicity: An unrecognized complication. Pediatr 1996, 97:717.
214. Priest JR, Watterson J, Jones RT, et al. Mutant fetal hemoglobin causing cyanosis in a newborn. Pediatrics 1989, 83:734.
215. Taddio A, Stevens B, Craig K, et al. Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. N Engl J Med 1997, 336:1197.
216. Tse S, Barrington K, Byrne P Methemoglobinemia associated with prilocaine use in neonatal circumcision. Am J Perinatol 1995, 12:331.
217. Yano SS, Danish EH, Hsia YE Transient methemoglobinemia with acidosis in infants. J Pediatr 1982, 100:415.